Dan‐Yun Ruan

1.3k total citations
50 papers, 935 citations indexed

About

Dan‐Yun Ruan is a scholar working on Oncology, Hepatology and Cancer Research. According to data from OpenAlex, Dan‐Yun Ruan has authored 50 papers receiving a total of 935 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 18 papers in Hepatology and 17 papers in Cancer Research. Recurrent topics in Dan‐Yun Ruan's work include Hepatocellular Carcinoma Treatment and Prognosis (15 papers), Inflammatory Biomarkers in Disease Prognosis (11 papers) and Liver Disease Diagnosis and Treatment (10 papers). Dan‐Yun Ruan is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (15 papers), Inflammatory Biomarkers in Disease Prognosis (11 papers) and Liver Disease Diagnosis and Treatment (10 papers). Dan‐Yun Ruan collaborates with scholars based in China, United States and South Korea. Dan‐Yun Ruan's co-authors include Xiaokun Ma, Xing Li, Xiangyuan Wu, Qu Lin, Dong‐Hao Wu, Rui‐Hua Xu, Zhan‐Hong Chen, Jing‐Yun Wen, Min Dong and Yan‐Fang Xing and has published in prestigious journals such as Cell, Journal of Clinical Oncology and Gastroenterology.

In The Last Decade

Dan‐Yun Ruan

49 papers receiving 925 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dan‐Yun Ruan China 17 407 286 285 236 230 50 935
Susanna V. Ulahannan United States 17 524 1.3× 324 1.1× 168 0.6× 217 0.9× 217 0.9× 89 1.1k
Yi‐Peng Fu China 17 389 1.0× 205 0.7× 259 0.9× 137 0.6× 176 0.8× 32 816
Amy K. Kim United States 12 263 0.6× 269 0.9× 237 0.8× 140 0.6× 225 1.0× 28 976
Koji Miyahara Japan 17 309 0.8× 275 1.0× 335 1.2× 154 0.7× 276 1.2× 45 906
Shunjun Fu China 17 607 1.5× 360 1.3× 395 1.4× 285 1.2× 421 1.8× 48 1.2k
Maarten W. Nijkamp Netherlands 17 419 1.0× 346 1.2× 248 0.9× 119 0.5× 361 1.6× 51 1.1k
Nigel C. Bird United Kingdom 17 467 1.1× 373 1.3× 257 0.9× 100 0.4× 266 1.2× 28 1.1k
Xinyu Bi China 17 480 1.2× 361 1.3× 245 0.9× 216 0.9× 400 1.7× 100 1.2k
Kota Arima Japan 19 644 1.6× 259 0.9× 260 0.9× 231 1.0× 128 0.6× 71 1.1k
Hongyu Zhang China 16 334 0.8× 301 1.1× 213 0.7× 154 0.7× 89 0.4× 42 842

Countries citing papers authored by Dan‐Yun Ruan

Since Specialization
Citations

This map shows the geographic impact of Dan‐Yun Ruan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan‐Yun Ruan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan‐Yun Ruan more than expected).

Fields of papers citing papers by Dan‐Yun Ruan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dan‐Yun Ruan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan‐Yun Ruan. The network helps show where Dan‐Yun Ruan may publish in the future.

Co-authorship network of co-authors of Dan‐Yun Ruan

This figure shows the co-authorship network connecting the top 25 collaborators of Dan‐Yun Ruan. A scholar is included among the top collaborators of Dan‐Yun Ruan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dan‐Yun Ruan. Dan‐Yun Ruan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wei, Xiaoli, Dan‐Yun Ruan, Feng Wang, et al.. (2025). First-in-human phase 1 study of an orally bioavailable vascular-disrupting agent DX1002 in patients with advanced solid tumors. Cell Reports Medicine. 6(2). 101969–101969. 1 indexed citations
2.
3.
Wang, Feng, Dan‐Yun Ruan, & Rui‐Hua Xu. (2024). Challenges and opportunities in oncology drug development and clinical research in China. Cell. 187(7). 1578–1583. 17 indexed citations
4.
Ruan, Dan‐Yun, et al.. (2023). Development of antibody‐drug conjugates in cancer: Overview and prospects. Cancer Communications. 44(1). 3–22. 39 indexed citations
5.
Wang, Yingnan, Dan‐Yun Ruan, Zixian Wang, et al.. (2022). Targeting the cholesterol-RORα/γ axis inhibits colorectal cancer progression through degrading c-myc. Oncogene. 41(49). 5266–5278. 6 indexed citations
6.
Qi, Meng, Yun‐Xin Lu, Dan‐Yun Ruan, et al.. (2021). DNA methylation regulator-mediated modification patterns and tumor microenvironment characterization in gastric cancer. Molecular Therapy — Nucleic Acids. 24. 695–710. 30 indexed citations
7.
8.
Chen, Zhan‐Hong, Xing Li, Dong‐Hao Wu, et al.. (2017). Validation and ranking of seven staging systems of hepatocellular carcinoma. Oncology Letters. 14(1). 705–714. 21 indexed citations
9.
Wu, Dong‐Hao, Tiantian Wang, Dan‐Yun Ruan, et al.. (2017). Combination of ULK1 and LC3B improve prognosis assessment of hepatocellular carcinoma. Biomedicine & Pharmacotherapy. 97. 195–202. 32 indexed citations
10.
Li, Xing, Xiang Zhong, Zhan‐Hong Chen, et al.. (2016). Efficacy of Prophylactic Entecavir for Hepatitis B Virus-Related Hepatocellular Carcinoma Receiving Transcatheter Arterial Chemoembolization. Asian Pacific Journal of Cancer Prevention. 16(18). 8665–8670. 10 indexed citations
11.
12.
Li, Yang, Dan‐Yun Ruan, Huimin Yi, et al.. (2015). A three-factor preoperative scoring model predicts risk of recurrence after liver resection or transplantation in hepatocellular carcinoma patients with preserved liver function. Hepatobiliary & pancreatic diseases international. 14(5). 477–484. 14 indexed citations
13.
Ruan, Dan‐Yun. (2015). Poor oncologic outcomes of hepatocellular carcinoma patients with intra-abdominal infection after hepatectomy. World Journal of Gastroenterology. 21(18). 5598–5598. 24 indexed citations
14.
15.
Chen, Zhan‐Hong, Xiaokun Ma, Xing Li, et al.. (2015). Comparison of five models for end-stage liver disease in predicting the survival rate of patients with advanced hepatocellular carcinoma. Tumor Biology. 37(4). 5265–5273. 5 indexed citations
16.
Wang, Tiantian, Xing Li, Min Dong, et al.. (2015). MicroRNA-34a-5p enhances sensitivity to chemotherapy by targeting AXL in hepatocellular carcinoma MHCC-97L cells. Oncology Letters. 10(5). 2691–2698. 25 indexed citations
17.
Li, Xing, Xiang Zhong, Zhan‐Hong Chen, et al.. (2014). Hepatitis B Virus DNA Negativity Acts as a Favorable Prognostic Factor in Hepatocellular Carcinoma Patients. Asian Pacific Journal of Cancer Prevention. 15(22). 9635–9641. 11 indexed citations
18.
Wu, Dong‐Hao, Changchang Jia, Jie Chen, et al.. (2014). Autophagic LC3B overexpression correlates with malignant progression and predicts a poor prognosis in hepatocellular carcinoma. Tumor Biology. 35(12). 12225–12233. 77 indexed citations
19.
Li, Xing, Zhan‐Hong Chen, Xiaokun Ma, et al.. (2014). Neutrophil-to-lymphocyte ratio acts as a prognostic factor for patients with advanced hepatocellular carcinoma. Tumor Biology. 35(11). 11057–11063. 35 indexed citations
20.
Wu, Xiangyuan, Xing Li, Zhan‐Hong Chen, et al.. (2012). An optimized antiviral modification strategy for prevention of hepatitis B reactivation in patients undergoing prophylactic lamivudine and chemotherapy: a pilot study. Tumor Biology. 34(2). 909–918. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Susanna V. Ulahannan Breakdown of academic impact, for papers by Yi‐Peng Fu Breakdown of academic impact, for papers by Amy K. Kim Breakdown of academic impact, for papers by Koji Miyahara Breakdown of academic impact, for papers by Shunjun Fu Breakdown of academic impact, for papers by Maarten W. Nijkamp Breakdown of academic impact, for papers by Nigel C. Bird Breakdown of academic impact, for papers by Xinyu Bi Breakdown of academic impact, for papers by Kota Arima Breakdown of academic impact, for papers by Hongyu Zhang
Rankless by CCL
2026